Benitec Biopharma Inc. (BNTC)
| Market Cap | 24.43M |
| Revenue (ttm) | 4,000 |
| Net Income (ttm) | -16.21M |
| Shares Out | 8.17M |
| EPS (ttm) | -2.67 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 39,352 |
| Open | 2.85 |
| Previous Close | 2.98 |
| Day's Range | 2.85 - 3.19 |
| 52-Week Range | 2.30 - 10.49 |
| Beta | 1.64 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 12, 2021 |
About BNTC
Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy; and BB-103 for the treatment of chronic hepatitis B virus infection. The company was incorporated in 1995 and is headquartered in Hayward, California.
News
Benitec Biopharma Discloses Q1 2022 Financial Results
HAYWARD, Calif., Nov. 15, 2021 /PRNewswire/ -- Benitec Biopharma Inc. (NASDAQ: BNTC) ("Benitec" or "the Company"), a development-stage, gene therapy-focused, biotechnology company developing novel genet...
Benitec Biopharma Provides Operational Update and Releases its 2021 Fiscal Year-End Financial Results
HAYWARD, Calif., Sept. 20, 2021 /PRNewswire/ -- Benitec Biopharma Inc. (NASDAQ: BNTC) ("Benitec" or "the Company"), a development-stage, gene therapy-focused, biotechnology company developing novel gene...
Benitec Biopharma to present at H.C. Wainwright's 23rd Annual Global Investment Conference
HAYWARD, Calif., Sept. 13, 2021 /PRNewswire/ -- Benitec Biopharma, Inc. (NASDAQ: BNTC), a development-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on the p...
Benitec Biopharma Provides Overview of the BB-301 Phase 1b/2a Clinical Trial Design for 2022
HAYWARD, Calif., Sept. 8, 2021 /PRNewswire/ -- Benitec Biopharma Inc. (NASDAQ: BNTC), a development-stage biotechnology company focused on the advancement of novel genetic medicines, today provided an o...
Benitec Biopharma Provides Positive Updates on the BB-301 Pilot Dosing Study in Large Animals
HAYWARD, Calif., Sept. 8, 2021 /PRNewswire/ -- Benitec Biopharma Inc. (NASDAQ: BNTC), a development-stage biotechnology company focused on the advancement of novel genetic medicines, today provided an u...
Benitec Biopharma Provides Positive Regulatory Updates for the BB-301 Development Program; BB-301 Phase 1b/2a Clinica...
HAYWARD, Calif., Sept. 8, 2021 /PRNewswire/ -- Regulatory Update Highlights: Regarding European Regulatory Interactions: The BB-301 Pilot Dosing Study was viewed as an appropriate dose range finding stu...
Benitec Biopharma Increases Previously Announced Bought Deal Offering of Common Stock to $12.9 Million
HAYWARD, Calif., April 27, 2021 /PRNewswire/ -- Benitec Biopharma Inc. (NASDAQ: BNTC) ("Benitec" or "the Company"), a development-stage, gene therapy-focused, biotechnology company developing novel gene...
Benitec Biopharma Announces $7.5 Million Bought Deal Offering of Common Stock
HAYWARD, Calif., April 27, 2021 /PRNewswire/ -- Benitec Biopharma Inc. (NASDAQ: BNTC) ("Benitec" or "the Company"), a development-stage, gene therapy-focused, biotechnology company developing novel gene...
Benitec BioPharma Shares Rally: Technical Levels To Watch
Benitec BioPharma Inc. (NASDAQ: BNTC) shares rallied Tuesday following a filing by Morgan Stanley that showed the bank increased its stake in the Australian biotechnology company by 5.2%. The stock gain...
Why DLPN Stock And BNTC Stock Are Popping Off Today
Dolphin Entertainment Inc (NASDAQ: DLPN) shares are trading 150% higher after the company announced it launched a non-fungible token (NFT) creation and marketing division. Dolphin Entertainment produces...
BNTC Stock: One Big Investor Has Benitec Biopharma Shares Going Bonkers
Benitec Biopharma (BNTC) stock is rocketing higher in early morning trading on Tuesday after disclosing a new large stake in the company. The post BNTC Stock: One Big Investor Has Benitec Biopharma Shar...
Why Benitec Biopharma (BNTC) Stock Is Skyrocketing Today
The shares of Benitec Biopharma Inc (NASDAQ: BNTC) are trading 92.5% higher at $6.14 in the early pre-market session on Tuesday. What Happened: Benitec shares had closed at $3.19 on Monday.
Benitec Biopharma's Gene Therapy For Rare Muscle Disorder Shows Encouraging Action In Animal Studies
Benitec Biopharma Inc (NASDAQ: BNTC) reports an interim analysis of the BB-301 Pilot Dosing study conducted in large animal subjects. BB-301 a genetic medicine directly injected into the pharyngeal musc...
Benitec Biopharma Announces 2020 Annual Stockholder Meeting
HAYWARD, Calif., Dec. 7, 2020 /PRNewswire/ -- Benitec Biopharma, Inc. (NASDAQ: BNTC), today announced that its 2020 Annual Meeting of Stockholders will be held virtually on Wednesday December 9, 2020 at...
Benitec Biopharma Announces Closing of $11.5 Million Public Offering and Full Exercise of Underwriter's Option to Pur...
HAYWARD, Calif., Oct. 6, 2020 /PRNewswire/ -- Benitec Biopharma Inc. (NASDAQ: BNTC) ("Benitec" or "the Company"), a development-stage, gene therapy-focused, biotechnology company developing novel geneti...
Benitec Biopharma Announces Pricing of $10.0 Million Public Offering
HAYWARD, Calif., Oct. 2, 2020 /PRNewswire/ -- Benitec Biopharma Inc. (NASDAQ: BNTC) ("Benitec" or "the Company"), a development-stage, gene therapy-focused, biotechnology company developing novel geneti...
Benitec Biopharma Provides Operational Update and Releases its 2020 Fiscal Year-End Financial Results
HAYWARD, Calif., Sept. 23, 2020 /PRNewswire/ -- Benitec Biopharma Inc. (NASDAQ: BNTC) ("Benitec" or "the Company"), a development-stage, gene therapy-focused, biotechnology company developing novel gene...
Benitec Biopharma to present at H.C. Wainwright's 22nd Annual Global Investment Conference
HAYWARD, Calif., Sept. 1, 2020 /PRNewswire/ -- Benitec Biopharma, Inc.
Benitec Biopharma Provides Update on BB-301 Tissue Transduction Study
HAYWARD, Calif., July 8, 2020 /PRNewswire/ -- Benitec Biopharma, Inc. (NASDAQ: BNTC), a development-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on the pro...
Penny Stocks to Buy Using Technical Analysis for March 2020
Penny stocks can be dangerous, particularly in this economic environment – so quick thinking and stop losses will be your best friends.